
Neuroethics Today
Neuroethics Today
play_circle_filled
Listen And Subscribe
Latest Episode
I Joined a Psychedelics Clinical Trial: Now What? - Edward Jacobs
In the fourth episode of Season 5 on the Neuroethics of Psychedelics, we speak with Dr. Edward Jacobs about post-trial access to psychedelics among certain patients. Dr. Jacobs is currently a postdoctoral research fellow at Johns Hopkins’ Center for Psychedelic and Consciousness Research and the Associate Director of HOPE – The Hub at Oxford for Psychedelic Ethics. He is also a contributing writer to ‘The Ethics Corner’ at The Psychedelic Practitioner. In this episode, Dr. Jacobs discusses the challenges that can arise when participants who benefit from psychedelic treatments during clinical trials lose access to them once a study ends. Drawing on his work on post-trial access to psychedelics, he explores the ethical case for continued access, as well as the clinical, regulatory, and institutional infrastructure that would be needed to provide it safely and responsibly. Episode contributors: Host: Dr. Lavinia Uscatescu Audio editor: Sarah Schultz
About Neuroethics Today
It's time for Neuroethics to make today’s news. Katherine Bassil, an upcoming neuroscientist and neuroethics enthusiast, has always tried to advocate for bridging the fields of neuroscience and neuroethics together. The absence of similar enterprises from the community makes it even more difficult for Katherine to achieve her goal. Join Katherine on her mission to show that being a neuroscientist and Neuroethics advocate, is the way for responsible brain innovation. The Neuroethics Today Podcast brings you interviews with experts in the field, where Neuroethics will question the science. Access more episodes, subscribe, and learn more.








